Searchable abstracts of presentations at key conferences in endocrinology

ea0038p81 | Clinical practice/governance and case reports | SFEBES2015

Glycogenic hepatopathy: a tale infrequently told in the diabetes world

Khalily Naveed , Butt Nida , Dixon Anthony

We present the case of a 27-year-old man who was first diagnosed with type 1 diabetes mellitus when he presented with diabetic ketoacidosis (DKA) and during later admissions was found to have grossly abnormal liver function tests. Following diagnosis, his diabetic control has been a challenge to manage despite the patient’s claim he had been taking his insulin ‘religiously’. He has had repeated admissions with DKA and has failed to attend clinic follow-ups on se...

ea0031p26 | Bone | SFEBES2013

Audit of primary hyperparathyroidism management: do we adhere to the guidelines?

Vas Prashanth , Tariq Adnan , Butt Muhammad

Introduction: Primary hyperparathyroidism (PPTH) is a common referral to endocrine clinics with a clinical spectrum ranging from an asymptomatic state to a symptomatic disorder with or without end organ damage. We audited our management against the NIH guidelines which are endorsed by the Endocrine Society.Methods: There is no outpatient coding system to correctly identify all patients with primary hyperparathyroidism. We included patient on radiology da...

ea0031p80 | Clinical practice/governance and case reports | SFEBES2013

Hypercalcaemia due to simultaneous presentation of primary hyperparathyroidism and metastatic oesophageal cancer

Tan Hiang Leng , Waheed Najeeb , Butt Muhammad

Introduction: We report a patient with hypercalcaemia secondary to parathyroid hormone related peptide (PTHrp) from metastatic oesophageal cancer and co-existing primary hyperparathyroidism.Case report: A 52-year-old lady was admitted to the hospital with a 2-week history of right scapula pain, reduced appetite and weight loss.Blood test revealed an adjusted calcium of 3.99 nmol/l (NR 2.1–2.55 nmol/l), PTH of 147 ng/l (NR 15&#...

ea0031p386 | Thyroid | SFEBES2013

Successful pregnancy outcomes with thyroxine treatment in euthyroid women with positive thyroid autoantibodies and recurrent miscarriage

Shonibare Tolulope , Waheed Najeeb , Butt Muhammad

We present two thyroid antibody positive euthyroid women with history of recurrent miscarriage who had successful pregnancy outcome when treated with levothyroxine.A 31-year-old Caucasian lady was referred to our endocrine services with a history of three previous miscarriages. She had strongly positive thyroid peroxidise antibodies (TPO) with normal thyroid function tests.We commenced her on 25 μg of levothyroxine. Within two...

ea0029p395 | Clinical case reports - Pituitary/Adrenal | ICEECE2012

An uncommon cause of hypoglycaemia: a case report

Tan H. , Butt M. , Waheed N.

Introduction: Hypoglycaemia in a non-diabetic patient is not a common condition and is often a diagnostic challenge.Case report: A 78-year-old gentleman was admitted to hospital by paramedics when his neighbours found him unresponsive. He had a background history of primary hypothyroidism. Capillary blood glucose reading done on site was 1.0 mmol/l. He received intravenous glucose which resulted in prompt recovery. All other vital signs were normal.<...

ea0029p455 | Clinical case reports - Thyroid/Others | ICEECE2012

Primary hyperparathyroidism and metastatic breast cancer: a simultaneous presentation

Tan H. , Waheed N. , Butt M.

Introduction: Hypercalcaemia is a frequent complication of breast cancer with bony metastasis. There is also an increase incidence of primary hyperparathyroidism among patients with breast cancer. We report a patient with breast cancer presenting with hypercalcaemia secondary to both parathyroid hormone- related peptide (PTHrP) from liver metastasis and possibly co-existing primary hyperparathyroidism.Case report: A 53 year old woman, with a history of r...

ea0028p235 | Obesity, diabetes, metabolism and cardiovascular | SFEBES2012

Hypoglycaemia documented with continuous glucose sensing in a case of “dead in bed”

Waheed Najeeb , Butt Muhammad , Dayan Colin

We report a 41 yr old man who was found dead in his bed with a continuous glucose monitoring device in situ. He had type 1 diabetes diagnosed at age 14 years. He had poor glycaemic control during his teenage years and suffered from severe hypoglycaemic episodes and reduced hypoglycaemic awareness resulting in three road traffic accidents. His diabetes was complicated by proliferative retinopathy, nephropathy and peripheral neuropathy. He began continuous subcutaneous insulin p...

ea0028p277 | Pituitary | SFEBES2012

Recurrent neutropenia associated with the use of dopamine agonists

Butt Muhammad , Waheed Najeeb , Kalk John

A 38 year lady was referred with a five month history of secondary amenorrhea, galactorrhoea, failure to conceive and elevated prolactin levels of 2023 miu/L (reference 102–496 miu/L). She could not undertake an MRI scan of the pituitary gland as she was claustrophobic and hence a CT scan was performed which did not show and gross pituitary lesion. Microprolactinoma was diagnosed and she commenced bromocriptine. She had normal white blood cells and neutrophil count prior ...

ea0065p384 | Reproductive Endocrinology and Biology | SFEBES2019

Its not just the baby that grows in pregnancy

Haider Najaf , Butt Nouman , Millar Kate , Kar Partha

Pituitary apoplexy is a rare but life threatening condition if not diagnosed and treated promptly. Common causes include hypertension, head trauma, major surgery, dynamic pituitary tests, anticoagulant use and pregnancy. In pregnancy, hyperplasia and hypertrophy of the lactotroph cells increase pituitary volume by 45% returning to original size at 6 months post-partum. Pituitary apoplexy is uncommon in pregnancy and an underlying adenoma is usually the cause. Very few...

ea0062cb6 | Additional Cases | EU2019

Resistant Grave’s disease not amenable to Thionamides, Thyroidectomy and Radioactive iodine

Haider Najaf , Sim Sing , Butt Nouman , Cranston Iain

Grave’s disease is an auto-immune condition associated with hyperthyroidism caused by TSH-receptor antibodies (TRAB) expressed by follicular cells of the thyroid gland. Grave’s ophthalmopathy has been reported in 25% of the patients and is rarely associated with dermopathy and thyroid acropachy. Management is by anti-thyroid drugs, radioactive iodine ablation or surgery, either alone or in combination. We present a rare case of resistant Graves who has detectable ant...